Eli Lilly is reducing the price of its 2.5 milligram and 5 milligram Zepbound vials, a move aimed at countering cheaper copycats of the obesity medication. The company lowered the cost to $349 a month for the 2.5 milligram version and $499 for the 5 milligram version, roughly half the list price of its standard version. This price adjustment is part of Eli Lilly’s effort to combat competition from lower-priced alternatives.
Source: https://www.bloomberg.com/news/articles/2025-02-25/zepbound-cost-for-vials-cut-to-battle-cheaper-copycats